Stereotaxis Inc Stock OTC Bulletin Board
Equities
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
|
07-01 | Stereotaxis, Inc.(NYSEAM:STXS) added to Russell Small Cap Comp Value Index | CI |
07-01 | Stereotaxis, Inc.(NYSEAM:STXS) added to Russell Small Cap Completeness Index | CI |
Sales 2024 * | 30.4M 41.58M | Sales 2025 * | 43.6M 59.64M | Capitalization | 165M 226M |
---|---|---|---|---|---|
Net income 2024 * | -18M -24.62M | Net income 2025 * | -15M -20.52M | EV / Sales 2024 * | 5.43 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.79 x |
P/E ratio 2024 * |
-8.38
x | P/E ratio 2025 * |
-9.14
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.16% |
Latest transcript on Stereotaxis Inc
Managers | Title | Age | Since |
---|---|---|---|
David Fischel
CEO | Chief Executive Officer | 57 | 16-09-28 |
Kimberly Peery
DFI | Director of Finance/CFO | 55 | 02-12-31 |
Laura Garth
LAW | General Counsel | - | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Messey
BRD | Director/Board Member | 78 | 05-04-30 |
David Fischel
CEO | Chief Executive Officer | 57 | 16-09-28 |
Nathan Fischel
BRD | Director/Board Member | 68 | 17-02-02 |
1st Jan change | Capi. | |
---|---|---|
+2.62% | 208B | |
+6.44% | 182B | |
+29.61% | 155B | |
+34.96% | 115B | |
+2.97% | 66.52B | |
+17.38% | 53.93B | |
-4.51% | 46.26B | |
-5.77% | 38.22B | |
+3.71% | 36.6B |